- Home
- TRIB vs ALLR Comparison
TRIB vs ALLR Comparison
Compare TRIB & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- ALLR
- Stock Information
- Founded
- TRIB 1992
- ALLR 2004
- Country
- TRIB Ireland
- ALLR United States
- Employees
- TRIB N/A
- ALLR N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- ALLR Health Care
- Exchange
- TRIB Nasdaq
- ALLR Nasdaq
- Market Cap
- TRIB 14.0M
- ALLR 15.8M
- IPO Year
- TRIB N/A
- ALLR N/A
- Fundamental
- Price
- TRIB $0.73
- ALLR $0.98
- Analyst Decision
- TRIB
- ALLR
- Analyst Count
- TRIB 0
- ALLR 0
- Target Price
- TRIB N/A
- ALLR N/A
- AVG Volume (30 Days)
- TRIB 2.4M
- ALLR 411.4K
- Earning Date
- TRIB 08-13-2025
- ALLR 08-04-2025
- Dividend Yield
- TRIB N/A
- ALLR N/A
- EPS Growth
- TRIB N/A
- ALLR N/A
- EPS
- TRIB N/A
- ALLR N/A
- Revenue
- TRIB $61,555,000.00
- ALLR N/A
- Revenue This Year
- TRIB $13.51
- ALLR N/A
- Revenue Next Year
- TRIB $13.14
- ALLR N/A
- P/E Ratio
- TRIB N/A
- ALLR N/A
- Revenue Growth
- TRIB 8.31
- ALLR N/A
- 52 Week Low
- TRIB $0.48
- ALLR $0.61
- 52 Week High
- TRIB $3.44
- ALLR $7.38
- Technical
- Relative Strength Index (RSI)
- TRIB 54.92
- ALLR 53.07
- Support Level
- TRIB $0.70
- ALLR $0.99
- Resistance Level
- TRIB $0.75
- ALLR $1.04
- Average True Range (ATR)
- TRIB 0.06
- ALLR 0.05
- MACD
- TRIB 0.00
- ALLR -0.00
- Stochastic Oscillator
- TRIB 68.47
- ALLR 43.33
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.